Ranbaxy's Globalization Strategies and its Foray Into the US

            
 
Strategic Management|Management Strategy |Business Strategy Case Study|Business Strategy|Case Study|Case Studies

ICMR HOME | Case Studies Collection

To download Ranbaxy's Globalization Strategies and its Foray Into the US case study (Case Code: BSTR188) click on the button below, and select the case from the list of available cases:

Business Ethics Case Studies | Case Study in Management, Operations, Strategies, Business Ethics, Case Studies

OR


Buy With PayPal

Amount to be paid:



Prefer to pay in another currency ?
Select Currency for Payment



Exchange Rates: Click Here
Delivery Details: Click Here

Business Strategy Case Studies
Case Studies Collection
Business Strategy Short Case Studies
View Detailed Pricing Info
How To Order This Case
Business Case Studies
Case Studies by Area
Case Studies by Industry
Case Studies by Company

Custom Search



Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.



Chat with us

Strategic Management Formulation, Implementation, & Control, 12e

Please leave your feedback

Leave Your Feedback

ICMR India ICMR India ICMR India ICMR India RSS Feed

Case Details:

Price:

Case Code : BSTR188 Electronic Format: Rs. 400;
Courier (within India):Rs. 25 Extra
Business Strategy | Case Study in Management, Operations, Strategies, Business Strategy, Case Studies

Themes

International Business | Growth and Challenges
Case Length : 17 Pages
Period : 1995-2005
Organization : Ranbaxy
Pub Date : 2005
Teaching Note : Not Available
Countries : US, India
Industry : Pharma and Biotech

Abstract:

The case discusses the globalization efforts of Ranbaxy Laboratories (Ranbaxy), a leading pharma company in India. Ranbaxy started off distributing drugs in foreign countries and went on to play a major role in the global generics market. By 2004, the company had manufacturing plants in 10 locations, ground operations in 45 countries and its products were sold in 70 countries across the world. The case describes Ranbaxy's foray in the US markets where it made a slow entry and adopted the route of Para IV filings to challenge the supremacy of big pharma companies. By the first quarter of 2005, Ranbaxy's sales in the US decreased by US$ 25 million, which was attributed to severe price erosion in these markets due to increasing competition among the US generics. The case describes the challenges facing the company in the US and examines Ranbaxy's growth strategy for the US markets.


Issues:

Entry and expansion strategies of Ranbaxy in foreign markets
Growth initiatives of Ranbaxy in the US
Challenges faced by Ranbaxy in the US

Contents:

  Page No.
Challenging American Pharma Companies 1
Background Note 2
The Globalization Efforts 4
The Globalization Strategy 7
Ranbaxy in the US 9
The Road Ahead 10
Exhibits 13

Keywords:

Ranbaxy Labs, Globalization, Global Acquisitions, Patents Claim, Lipitor, Generic Drugs, Patent Protection, Research and Development, Active Pharmaceutical Ingredient, Ranbaxy-Pfizer Dispute

Ranbaxy's Globalization Strategies and its Foray Into the US - Next Page>>

 

Case Studies Links:- Case Studies, Short Case Studies, Simplified Case Studies.

Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.

Business Reports Link:- Business Reports.

Books:- Textbooks, Work Books, Case Study Volumes.